Scott Silveira
This is a randomized, double-blind, placebo-controlled, two-arm crossover clinical trial evaluating the effects of nicotinamide mononucleotide (NMN) combined with trimethylglycine (TMG) supplementation, compared to NMN alone. The study will assess safety and efficacy in improving exercise tolerance and modulating biomarkers of aging in healthy older adults. The primary outcome is cycle ergometry constant work rate (CWR) exercise tolerance, measured as time to fatigue. Secondary outcomes include changes in peak oxygen consumption (VO₂peak), critical power, anaerobic work capacity, lactate threshold, and NAD⁺ metabolite levels. The supplements have been used in prior exploratory studies and real-world applications, which have helped inform the design of this current trial.
This randomized, double-blind, placebo-controlled, two-arm crossover trial will compare the effects of two NAD⁺-modulating interventions-nicotinamide mononucleotide (NMN) with trimethylglycine (TMG) and conventional NMN supplementation-on exercise tolerance and metabolic biomarkers in healthy older adults. The NMN and TMG arm will involve a twice-daily oral dose containing 1000 mg of NMN and 500 mg of TMG, while the comparison arm will involve twice-daily oral dose of 1000 mg of NMN per day. Doses will be self-administered each morning and evening with water. The primary endpoint is time to f…
Inclusion Criteria: * Adults aged 60 to 80 years, of any sex * Written clearance from primary care physician confirming medical fitness to participate in an exercise-based clinical study * Normal or near-normal cardiovascular function to safely engage in moderate to vigorous exercise, demonstrated by either: stress echocardiogram or coronary CT angiogram within the past 12 months showing normal left ventricular function, no significant valvular heart disease, no ischemic changes, and no other clinically significant abnormalities, plus confirmation that no new cardiovascular symptoms (e.g., ch…
Formulation containing NMN and TMG.
Conventional NMN supplement.
Organoleptically matched inert control.
Arctuva estimate
Actual pay is set by the research site.
Verify or correct the compensation shown for this listing.